CoreSite Realty Corporation (COR) News
Filter COR News Items
COR News Results
| Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
COR News Highlights
- COR's 30 day story count now stands at 2.
- Over the past 7 days, the trend for COR's stories per day has been choppy and unclear. It has oscillated between 1 and 1.
- The most mentioned tickers in articles about COR are TEVA.
Latest COR News From Around the Web
Below are the latest news stories about CENCORA INC that investors may wish to consider to help them evaluate COR as an investment opportunity.
Why This 1 Momentum Stock Could Be a Great Addition to Your PortfolioWondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores. |
Here's Why Cencora (COR) is a Strong Value StockThe Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage. |
Sapphiros and Cencora, formerly AmerisourceBergen Corporation, Enter into Distribution AgreementSapphiros, a platform company dedicated to building the next generation of consumer diagnostic technologies, is proud to announce it has entered into a distribution agreement with Cencora, Inc. (NYSE: COR), formerly AmerisourceBergen Corporation. |
3 Biotech Stocks You’ll Regret Not Buying Soon: November 2023The global biotechnology market could nearly triple by 2030. |
Why This 1 Growth Stock Could Be a Great Addition to Your PortfolioWondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores. |
Walgreens cuts Cencora stake further in $674 million share saleAfter the share repurchase, Walgreens now owns approximately 15% in drug distributor Cencora, it said, adding that it would use the proceeds to pay down debt. AmerisourceBergen disclosed plans early this year to rename itself as Cencora in a bid to expand internationally beyond drug distribution. |
Cencora Announces Common Share Repurchase From Walgreens Boots AllianceCONSHOHOCKEN, Pa., November 09, 2023--Cencora, Inc. (NYSE: COR), formerly AmerisourceBergen Corporation, today announced that it has agreed to repurchase shares of its common stock from Walgreens Boots Alliance Holdings LLC in the amount of approximately $250 million in concurrence with Walgreens Boots Alliance’s entry into certain variable pre-paid forward transactions executed in reliance on Rule 144 under the Securities Act of 1933, as amended. |
Judge trims US lawsuit accusing Cencora of fueling opioid epidemicA federal judge on Monday pared back a U.S. government lawsuit accusing drug distributor Cencora , formerly called AmerisourceBergen, of fueling the nation's deadly opioid epidemic by failing to report hundreds of thousands of suspicious orders of prescription painkillers. U.S. District Judge Jerry Pappert in Philadelphia federal court ruled that the government could only seek penalties for alleged failure to report suspicious orders after October 2018, when the federal Controlled Substances Act was amended to explicitly require such reports. The government's lawsuit, filed last December, claimed that the company failed to report suspicious orders going back to 2014. |
Why Cencora (COR) is a Top Value Stock for the Long-TermWondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores. |
Cencora, Inc. (COR) Hit a 52 Week High, Can the Run Continue?Cencora (COR) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues. |